Skip to main content
TipRanks
Go Ultimate75% OFF

Brain Scientific (BRSF) Ratios

7 Followers

Brain Scientific Ratios

BRSF's free cash flow for Q4 2022 was $-1.25M. For the 2022 fiscal year, BRSF's free cash flow was decreased by $-5.83K and operating cash flow was $-1.24M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 22Mar 22Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio0.180.260.060.240.78
Quick Ratio0.160.230.040.240.78
Cash Ratio0.100.180.030.220.72
Solvency Ratio-1.55-0.63-1.25-0.84-6.09
Operating Cash Flow Ratio-0.80-1.35-0.44-0.72-4.90
Short-Term Operating Cash Flow Coverage-2.14-7.16-1.43-0.98-22.25
Net Current Asset Value$ -6.12M$ -12.94M$ -2.10M$ -897.21K$ -55.97K
Leverage Ratios
Debt-to-Assets Ratio0.240.803.383.020.35
Debt-to-Equity Ratio0.66-15.33-0.38-0.98-1.16
Debt-to-Capital Ratio0.401.07-0.61-52.187.29
Long-Term Debt-to-Capital Ratio0.001.08-0.060.000.00
Financial Leverage Ratio2.72-19.25-0.11-0.32-3.34
Debt Service Coverage Ratio-1.24-6.04-4.05-1.07-6.14
Interest Coverage Ratio-2.67-15.52-93.96-29.47-8.07
Debt to Market Cap29.091.540.040.060.01
Interest Debt Per Share6.7931.052.514.031.51
Net Debt to EBITDA-0.27-1.19-0.25-0.640.08
Profitability Margins
Gross Profit Margin25.32%31.32%53.28%20.85%41.60%
EBIT Margin-4072.67%-3214.73%-2956.83%-198.32%-2211.42%
EBITDA Margin-3697.60%-3132.01%-2938.31%-198.05%-2210.29%
Operating Profit Margin-4478.11%-3257.41%-2956.84%-198.32%-2211.42%
Pretax Profit Margin-5753.00%-3424.57%-2992.64%-204.75%-2454.02%
Net Profit Margin-5753.00%-3424.57%-2992.64%-205.20%-2454.02%
Continuous Operations Profit Margin-5753.00%-3424.57%-2992.64%-205.20%-2454.02%
Net Income Per EBT100.00%100.00%100.00%100.22%100.00%
EBT Per EBIT128.47%105.13%101.21%103.24%110.97%
Return on Assets (ROA)-105.11%-68.04%-1245.07%-344.97%-791.78%
Return on Equity (ROE)-285.92%1309.58%139.62%112.10%2642.30%
Return on Capital Employed (ROCE)-222.18%-95.85%146.06%108.34%2741.47%
Return on Invested Capital (ROIC)-133.81%-86.95%222.25%5761.57%-14983.33%
Return on Tangible Assets-775.15%-590.40%-1245.07%-344.97%-791.78%
Earnings Yield-12952.63%-134.26%-13.36%-6.67%-14.62%
Efficiency Ratios
Receivables Turnover226.5715.7064.1588.070.00
Payables Turnover0.150.170.111.260.24
Inventory Turnover1.071.250.970.000.00
Fixed Asset Turnover1.020.841.02292.2429.07
Asset Turnover0.020.020.421.680.32
Working Capital Turnover Ratio-0.05-0.10-0.06-1.03-0.12
Cash Conversion Cycle-2107.61-1886.44-2940.63-286.05-1501.74
Days of Sales Outstanding1.6123.245.694.140.00
Days of Inventory Outstanding340.67292.15374.520.000.00
Days of Payables Outstanding2449.892201.833320.84290.201501.74
Operating Cycle342.28315.39380.214.140.00
Cash Flow Ratios
Operating Cash Flow Per Share-6.23-16.25-2.95-3.78-7.58
Free Cash Flow Per Share-6.26-16.42-3.05-3.78-7.59
Dividend Paid and CapEx Coverage Ratio-178.27-100.04-30.68-850.47-973.48
Capital Expenditure Coverage Ratio-178.27-100.04-30.68-850.47-973.48
Operating Cash Flow Coverage Ratio-2.07-0.55-1.22-0.97-17.79
Operating Cash Flow to Sales Ratio-27.66-22.08-9.95-1.75-19.15
Free Cash Flow Yield-6262.71%-87.42%-4.59%-5.69%-11.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.01-0.74-7.48-14.98-6.84
Price-to-Sales (P/S) Ratio0.4425.51223.9230.75167.82
Price-to-Book (P/B) Ratio0.02-9.75-10.45-16.80-180.70
Price-to-Free Cash Flow (P/FCF) Ratio-0.02-1.14-21.80-17.58-8.76
Price-to-Operating Cash Flow Ratio-0.02-1.16-22.51-17.60-8.77
Price-to-Earnings Growth (PEG) Ratio0.00-0.00-0.070.28-0.15
Enterprise Value Multiple-0.28-2.00-7.87-16.16-7.51
Enterprise Value2.21M16.64M21.67M15.66M9.65M
EV to EBITDA-0.28-2.00-7.87-16.16-7.51
EV to Sales10.3062.63231.3132.01166.09
EV to Free Cash Flow-0.37-2.81-22.52-18.30-8.67
EV to Operating Cash Flow-0.37-2.84-23.25-18.32-8.67
Tangible Book Value Per Share-6.12-34.71-6.36-3.96-0.37
Shareholders’ Equity Per Share4.53-1.93-6.36-3.96-0.37
Tax and Other Ratios
Effective Tax Rate0.000.000.00-0.000.00
Revenue Per Share0.230.740.302.160.40
Net Income Per Share-12.95-25.21-8.88-4.44-9.72
Tax Burden1.001.001.001.001.00
Interest Burden1.411.071.011.031.11
Research & Development to Revenue1.411.242.250.213.62
SG&A to Revenue40.3827.7325.741.6116.31
Stock-Based Compensation to Revenue0.000.013.800.000.00
Income Quality0.480.640.330.850.78

Currency in USD